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Abstrak
Latar belakang: Infeksi Saluran Pernafasan Akut Berat (SARI) atau pneumonia memiliki kontribusi besar 
dalam morbiditas dan mortalitas, namun Indonesia masih belum memiliki data epidemiologi yang cukup. 
Tujuan dari penelitian ini adalah untuk mengetahui pola epidemiologi virus infl uenza sebagai etiologi 
kasus SARI.
Metode: Analisis ini didasarkan pada surveilans sentinel SARI  yang dilakukan oleh Pusat Biomedis dan 
Teknologi Dasar Kesehatan (Pusat BTDK) pada sembilan rumah sakit di sembilan provinsi di Indonesia pada 
tahun 2011. Setiap pasien yang memenuhi kriteria SARI  diikutsertakan dalam penelitian ini. Usap tenggorok 
dan hidung, serta serum diambil  dan diperiksa di laboratorium Virologi Pusat BTDK untuk menentukan 
etiologinya. RT-PCR digunakan untuk mendeteksi jenis dan subtipe virus infl uenza dari usap tenggorok/hidung.
Hasil: Sebanyak 333 kasus SARI didapatkan dari sembilan rumah sakit sentinel. Sebanyak 6% kasus yang 
positif infl uenza melalui pemeriksaan RT-PCR. Dari seluruh kasus SARI, proporsi infl uenza A adalah 5% 
dan infl uenza B 1%. Infl uenza A subtipe H1N1pdm09 mendominasi infl uenza musiman yang  beredar di 
Indonesia dari kasus SARI.
Kesimpulan: Virus Infl uenza  musiman didapat dari kasus-kasus SARI namun jumlahnya tidak terlalu banyak. 
Oleh karena itu, penyebab lain dari kasus SARI masih perlu diteliti. (Health Science Indones 2014;1:7-11) 
Kata kunci: SARI, Surveilans, Infl uenza
Abstract
Background: Severe Acute Respiratory Infection (SARI) or pneumonia has a major contribution in the 
morbidity and mortality, however, Indonesia still has lack of its epidemiology. The aim of the study is to 
know the epidemiological pattern of infl uenza virus as the etiology of SARI cases. 
Methods:This analysis based on the sentinel surveillanceSARI conducted by Center for Biomedical and 
Basic Technology of Health (CBBTH) of Indonesia carried out at nine hospitals in nine provinces in 2011.
Every patient who met the criteria of SARI was included in this study.  Serum, throat and nasal swabs were 
taken and examined at the Virology laboratory CBBTH to determine the etiology. RT-PCR  was used to 
detect type and subtype of  infl uenza viruses from swabs.
Results: Total number of SARI cases were 333. We found 6% cases were  infl uenza positive by RT-PCR. The 
proportion of infl uenza A was 5% and infl uenza B 1% from total SARI cases. We detected that seasonal infl uenza 
A subtype H1N1pdm09was the  dominant subtypes that circulating in Indonesia.
Conclusion: We foundseasonal Infl uenza infection from SARI patients, however, it was only small 
number. Therefore, further detection of SARI cases is needed. (Health Science Indones 2014;1:7-11)
Key words: SARI, surveillance, infl uenza
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Severe Acute Respiratory Infection (SARI) or 
Pneumonia is a form of acute infection in the lung 
tissue (alveoli or interstitial tissue) with fever and 
coughing as its clinical manifestations along with the 
diffi culty of breathing such as the condition of being 
breathless, the retraction of the chest wall and stridor 
during rest or results of thoracic imaging which 
indicates a pulmonary infi ltrate.1-3
Pneumonia is a health issue for the world, and not 
only for developing countries but also for developed 
countries such as the US, Canada, and European 
countries. Pneumonia causes a high percentage of 
death in the world for both babies and infants under 
the age of 5 (14.1%).4 According to Indonesia Basic 
Health Research data in 2007, pneumonia is the 
second leading cause of death after diarrhea among 
infants.
Pneumonia may be caused by bacteria, virus or 
mycoplasma, including infl uenza virus. Seasonal 
infl uenza virus is the second cause most commonly 
found among children suffering from pneumonia, 
and it contributes signifi cantly in cases of inpatient 
care and death among children under the age of 5 
around the world.6 Data from neighbouring countries 
showed that the infl uenza virus is one of the causes 
in SARI. In Thailand, among 28,543 patients with 
acute low respiratory tract infection from 2005-2010, 
infl uenza virus was detected in 8% of the patient.7 In 
Bangladesh, the incidence of SARI associated with 
infl uenza in children < 5 years old was estimated 
around 6% per  1000 person per years in 2008-2010.8 
In 2011,  Ministry of Health Indonesia data showed 
that severe pneumonia in children < 5 years old is 
around 0.9 % with CFR  0.14 %.9
While SARI has contributed a great amount of 
share in morbidity and mortality, up to this moment 
Indonesia still does not have any data regarding 
its epidemiology patternand the etiology of SARI. 
SARI surveillance primarily intended to detect and 
discover new variants or subtypes of Infl uenza virus, 
including strains that are potential of pandemics.1 
However, the other etiologies could cause SARI, 
such as bacteria.Therefore, SARI surveillance is 
highly crucial for early detection and characterization 
of SARI etiologies, both viruses and bacteria.1
METHODS
Study site
SARI surveillance is administered in ten sentinel 
hos pitals in Indonesia. They were the HasanSadikin 
Hospital Bandung, Tangerang Regional General Hos-
pital, Dr. Karyadi Hospital Semarang, Dr. Wahidin 
Sudiro Husodo Hospital Makassar, Mataram Regional 
General Hospital, and SuliantiSuroso Central Hospital 
for Infectious Disease Jakarta, Dr. M. Djamil Hospital 
Padang, Dr. Soedarso Hospital Pontianak, and DOC II 
Jayapura Hospital. 
Enrolment and data collection
January to December 2011, laboratory-enhanced res-
piratory surveillance was conducted at the in-patient 
department  of all nine sentinel hospital. During this 
period, trained health workers invited all patients 
which met defi nition operational of SARI to participate 
and enrolled to whom agreed. Next, health workers 
completed a questionnaire by patient interview and 
record review, and collected nasal and throat swabs, 
serum and sputum/blood to detect virus and bacteria 
causing the SARI. Surveillance case defi nitions were 
based on those devised by WHO both for children 
under fi ve years of age and for the older ages.
Laboratory methods
Nasal and throat swabs specimens, in 1 ml viral transport 
medium (VTM, prepared in-house), were transported 
to Virology laboratory, Center of Biomedical and 
Basic Technology of Health, NIHRD which is located 
in Jakarta under specifi c cold chain procedures. The 
specimens then stored in -80 C until analysis.RT-PCR 
test, virus culture and Hemagglutination Inhibition (HI) 
test were performed based on infl uenza virus detection 
procedures in WHO guidelines.10
Viral RNA was extracted from the VTM-Clinical 
Specimens using the QiAMP Viral mini kit (Qiagen, 
Germany) according to manufacturer’s intruction. 
The RNA was reverse transcribed polymerase chain 
reaction (RT-PCR) with the SuperScript III Reverse 
Transcriptase qPCR with Platinum Taq kit (Invitrogen, 
Carlsbad, CA - USA). RT-PCR amplifi cation was 
performed by using specifi c primers and probes of 
Infl uenza A, B, A/H1pdm09, A/H3N2, and A/H5N1 
according to CDC (Center Disease Control) Atlanta 
Protocol. An internal control human RNaseP PCR 
was included to confi rm the specimen adequacy 
and to identify PCR inhibition. Specimens were 
considered positive if a virus PCR cT value was < 38 
with appropriate run control results. 
Viruses were grown in MDCK (Madine Darby 
Canine Kidney) Cell only for nasal and throat 
swab specimens which shown Infl uenza positive 
results by RT-PCR test. Virus titration and subtype 
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identifi cation of the viruses was determined by standard 
haemagglutination and haemagglutination inhibition. 
Data management and analysis
Clinical and laboratory data were recorded on paper-
based case record forms. Those data are then entered 
and analyzedby an Microsoft Excell 2003.
RESULTS
A total of 333 cases were obtained from nine hospitals.
The distribution of cases each month is described in 
table 1 below. Number of SARI cases varied in each 
month with the peak on December. In some month, 
child cases are more frequent than adult.
From all cases, 59,5% were catagorized as children 
(<14 years old) and 41,4% as adult, 58% were man and 
the rest is women.The result of rRT-PCR for infl uenza 
showed  that 6 % of the SARI cases  specimens contain 
infl uenza virus (table 2). From all positive infl uenza, 
fl u A more dominan than Flu B. Infl uenza cases was 
only found in fi ve hospital in fi ve provinces; Makassar, 
Semarang, Mataram, Jakarta and Tangerang. One case 
of Avian Infl uenza cases was reported from Jakarta.
DISCUSSION
SARI surveillance is part of the Global Infl uenza 
Surveillance and Response Systems (GISRS). In 
a global level, the need of understanding infl uenza 
epidemiology is increasing signifi cantly after the 
outbreak of Avian Infl uenza A/H5N1 infl uenza and 
A/H1N1 infl uenza pandemic occurred in 2009. The 
Table 2. Distribution of Infl uenza cases per sentinel
Sentinels Flu B
Flu A
Neg Inf Total
H3 Hpdm09 H5
Dr. Hasan Sadikin Hospital, Bandung 0 0 0 0 77 77
Dr. Wahidin Sudirohusodo Hospital, Makassar 4 1 5 0 77 87
Mataram Hospital, 0 1 1 0 49 51
Dr. Kariadi Hospital, Semarang 0 2 1 0 24 27
Dr. Sulianti Saroso Hospital, Jakarta 0 0 0 1 3 4
Tangerang Hospital, 0 2 2 0 22 26
Dr. M. Djamil Hospital,Padang 0 0 0 0 37 37
RS Doc II Jayapura 0 0 0 0 17 17
Dr. Soedarso Hospital, Pontianak 0 0 0 0 7 7
Total 4 6 9 1 313 333
SARI surveillance is used to identify how many 
cases of infl uenza required inpatient care; while ILI 
(Infl uenza Like Illness) surveillance is used to obtain 
data of infl uenza cases from outpatient care.
SARI surveillance in Indonesia has been administered 
since 2008, long before the A/H1N1 infl uenza pandemic 
occurred in 2009. While in other countries, especially 
Europe, SARI surveillance is conducted after the 
pandemic took place, in Indonesia the surveillance was 
performed due to the human cases of  Avian Infl uenza 
A/H5N1 which fi rst reported in 2005.  Besides the 
expectation that SARI surveillance can  determine the 
distribution of cases and types of seasonal  infl uenza 
circulating in Indonesia, the surveillance is also 
expected to detect any human cases of Avian Infl uenza 
A/H5N1. In 2011, through the SARI surveillance, one 
case of A/H5N1 infl uenza was found in Tangerang 
Regional Hospital.
Table 1. Number of SARI cases per month in selected 
city/town in Indonesia in 2011
Adult Children Total
January 6 6 12
February 5 23 28
March 4 36 40
April 0 37 37
May 6 16 22
June 13 11 24
July 28 6 34
August 13 5 18
September 11 6 17
October 10 12 22
November 11 20 31
December 31 17 48
Total 138 195 333
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The sentinel system applied in the SARI surveillance 
are determined based on several considerations which 
include limited resources, both human, fi nancial and 
laboratory capacity, and also disease characteristics 
of infl uenza which are usually mild. According to the 
manual established by WHO for European regional, 
the sentinel system adopted by Indonesia is a simple 
system which include epidemiology and virology 
data collecting from several sites.11
SARI cases  obtained from sentinel hospitals varied by 
month and age group, but there is no signifi cant different 
between month. This may be infl uenced by many 
factors including.the variation of etiology SARI. For 
example, study in UK reported that SARI cases caused 
by Respiratory Syncytial Virus were found earlier than 
SARI cases caused by infl uenza during winter.12
As previously stated, SARI surveillance is aimed 
to detect infl uenza epidemiology.  The examination 
used in detecting the presence of infl uenza virus 
is by utilizing RT-PCR and virus culture. RT-PCR 
infl uenza test results on the SARI specimens showed 
that only 6% of the specimens which contain 
infl uenza virus. This is similar to the results found 
through SARI surveillance conducted in 2008-2009, 
where infl uenza virus was only found in 6 % of the 
cases.1 If further compared to the surveillance results 
in 2008-2009, there is also a difference in subtype 
Infl uenza A which was dominant; where in 2008-
2009  subtype A/H3N2 was dominant, while in 2011, 
subtype A/H1N1pdm09.13 In 2008-2009, 2 cases of 
A/H5N1 were found, while in 2011 only one case was 
found through the SARI surveillance.In other study 
conducted in Bangladesh, infl uenza contributed in 
about 4 to 6% of acute lower respiratory infection 
in children > 5 years, and only 1% in adult.8Study 
in Thailand showed that infl uenza was found in 8% 
children younger than 5 years hospitalized with acute 
lower respiratory tract infection.
However, SARI surveillance can be used as a tool 
in detecting novel infl uenza virus in Indonesia, 
which potential of causing  pandemic. It is crucial 
in considering the SARI surveillance sentinel 
system in a condition where human resources are 
limited such as in Indonesia. In the coming future, 
the improvement of surveillance system is required 
to detect novel infl uenza virus strains as the early 
warning of pandemic. In a global scale, WHO is 
continuing developSARI surveillance manual after 
the infl uenza pandemic occurred in 2009.
In conclusion, infl uenza contributed only in small 
percentages of SARI cases. Therefore the fi nding of 
other bacteria and viruses is  needed to be developed 
in the future.
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